Atsena closes $150m in Series C round to progress gene therapy
Bain Capital’s Life Sciences team led the funding round, with contributions from new investor Wellington Management.
Cytiva Pipe dream to pipeline WP 3
Alltrna plans to tackle rare diseases using tRNA-based therapies
Struggling bluebird bio to go private for less than $30m
Pfizer shelves haemophilia gene therapy Beqvez amid low demand
FDA grants fast track status to Rznomics’ RZ-001 for HCC
SmartCella gains rights to advance cell therapy research for Parkinson’s
Italian charity seeks EMA approval for rescued gene therapy
Thermo Fisher continues viral vector withdrawal; lays off 300 employees
